Brief: Geneuro To Present New Data At American Diabetes Association’s 78th Scientific Session
20/06/2018 17:03
June 20 (Reuters) - GENEURO SA GNRO.PA :
* GENEURO TO PRESENT NEW DATA SUPPORTING ROLE OF HUMAN
ENDOGENOUS
RETROVIRUSES IN TYPE 1 DIABETES AT AMERICAN DIABETES
ASSOCIATION’S (ADA) 78TH SCIENTIFIC SESSIONS
* GENEURO IS CURRENTLY CONDUCTING A PHASE IIA STUDY
(RAINBOW) WITH
GNBAC1, A MONOCLONAL ANTIBODY TARGETING PHERV-W ENV IN 60
PATIENTS WITH T1D
* INITIAL 6-MONTHS RESULTS ARE EXPECTED BY THE END OF
SEPTEMBER
2018
Source text for Eikon: ID:nBw3TQ509a
Further company coverage: GNRO.PA
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Geneuro SA
See all newsBrief: Geneuro SA Postpones Publication Of Half-Yearly Financial Report
Brief: Geneuro SA Announces Extension Of Its Definitive Debt-Restructuring Moratorium
Brief: Geneuro SA Announces The Opening Of Receivership Proceedings For Its French Subsidiary Geneuro Innovation Sas
Brief: Geneuro Confirms Top-Line Results In Its Post-Covid Trial By End-June
Brief: Geneuro announces EUR 5 Mln private placement